Wells Fargo analyst Aaron Rakers raised the price target on Marvell (NASDAQ: MRVL) to $365 (from $310) while maintaining an Overweight rating.

“We think MRVL delivered against relatively high expectations w/ CY30 / FY31 EPS guide of >$30 driven by broad interconnect + custom silicon momentum; expanded design wins & material XPU-attach uplift.

Raising ests. & PT to $365 (~26x CY28 P/E).

Key Takeaway: We think the event emphasized MRVL’s impressive connectivity portfolio breadth and growing custom silicon positioning across a diversifying number of customers & programs (notable XPU-attach momentum).

We see MRVL best positioned to benefit from an increasingly heterogeneous interconnect landscape w/ portfolio spanning scale-across/out/up/in (PAM, coherent & coherent-lite pluggables, AECs, switch ASICs, NPO, CPO) across major protocols (Ethernet / ESUN, UALink, & NVLink Fusion).”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

This callScored on Apr 8, 2027, six months after the note: did MRVL reach $365?

Firm track recordWells Fargo reached 73% of its 41 scored targets within six months (#10 of 31 firms). Accuracy ranking →

Wells Fargo on Marvell · target history
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.